Qorvo (QRVO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Compass Therapeutics, Inc. (CMPX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Amylyx Pharmaceuticals, Inc. (AMLX) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates ...

Why has the Bank of England cut the base rate? At the first opportunity this year, the base rate has been reduced by 0.25 ...

“People will always want to talk about why they want particular songs to win or what they mean in their lives ... It wasn’t until Spiderbait’s Buy Me a Pony in 1996 that Australia had ...

“Product of Canada” applies when a food product’s primary ingredients, processing and associated labour are Canadian. The minor use of ingredients not typically grown or produced in Canada, such as ...

You'll need to submit tax updates every three months' Mike Croxford, Which? Money expert, says... Making Tax Digital requires ...

Suggestion that the US take over and redevelop the war-torn region, and displace its Palestinian residents, has been condemned by Arab allies but welcomed by Israel ...